These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 33199429)

  • 1. Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer ≥2 cm.
    Rendón GJ; Lopez Blanco A; Aragona A; Saadi JM; Di Guilmi J; Arab Eblen C; Heredia Muñoz F; Pareja R
    Int J Gynecol Cancer; 2021 Mar; 31(3):462-467. PubMed ID: 33199429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility sparing therapy in women with lymph node negative cervical cancer >2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy.
    Plaikner A; Siegler K; Hertel H; Jacob A; Petzel A; Schubert M; Blohmer JU; Böhmer G; Marnitz S; Ragosch V; Domröse C; Oppelt P; Jülicher A; Schneider A; Willems A; Favero G; Köhler C
    Int J Gynecol Cancer; 2023 Oct; 33(10):1542-1547. PubMed ID: 37696645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.
    Tesfai FM; Kroep JR; Gaarenstroom K; De Kroon C; Van Loenhout R; Smit V; Trimbos B; Nout RA; van Poelgeest MIE; Beltman JJ
    Int J Gynecol Cancer; 2020 Jan; 30(1):115-121. PubMed ID: 31744889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2 cm: a pilot study.
    de Vincenzo R; Ricci C; Fanfani F; Gui B; Gallotta V; Fagotti A; Ferrandina G; Scambia G
    Fertil Steril; 2021 Jan; 115(1):148-156. PubMed ID: 33092819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer.
    Fanfani F; Pedone Anchora L; Di Martino G; Bizzarri N; Di Meo ML; Carbone V; Paderno M; Fedele C; Paniga C; Fagotti A; Landoni F; Scambia G; Buda A
    Int J Gynecol Cancer; 2021 Mar; 31(3):452-456. PubMed ID: 33649013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility-sparing surgery after neo-adjuvant chemotherapy in women with cervical cancer larger than 4 cm: a systematic review.
    Viveros-Carreño D; Rodriguez J; Rendon Pereira GJ; Slama J; Halaska MJ; Robova H; Pareja R
    Int J Gynecol Cancer; 2022 Apr; 32(4):486-493. PubMed ID: 35210296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
    Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
    Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.
    Plante M; van Trommel N; Lheureux S; Oza AM; Wang L; Sikorska K; Ferguson SE; Han K; Amant F
    Int J Gynecol Cancer; 2019 Jun; 29(5):969-975. PubMed ID: 31101688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives.
    Gwacham NI; McKenzie ND; Fitzgerald ER; Ahmad S; Holloway RW
    Gynecol Oncol; 2021 Sep; 162(3):809-815. PubMed ID: 34130862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conization and lymph node evaluation as a fertility-sparing treatment for early stage cervical cancer.
    Martinelli F; Ditto A; Filippi F; Vinti D; Bogani G; Leone Roberti Maggiore U; Evangelista M; Signorelli M; Chiappa V; Lopez S; Somigliana E; Raspagliesi F
    Int J Gynecol Cancer; 2021 Mar; 31(3):457-461. PubMed ID: 33649014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?
    Noll F; Palacios Torres AT; Pecci P; Lucchini SM; Heredia F
    Int J Gynecol Cancer; 2021 Mar; 31(3):379-386. PubMed ID: 33649005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of less radical fertility-sparing procedures with omitted parametrectomy for cervical cancer: 5years of experience.
    Slama J; Cerny A; Dusek L; Fischerova D; Zikan M; Kocian R; Germanova A; Cibula D
    Gynecol Oncol; 2016 Sep; 142(3):401-4. PubMed ID: 27396943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.
    Zusterzeel PLM; Aarts JWM; Pol FJM; Ottevanger PB; van Ham MAPC
    Oncologist; 2020 Jul; 25(7):e1051-e1059. PubMed ID: 32339376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study.
    Slama J; Runnebaum IB; Scambia G; Angeles MA; Bahrehmand K; Kommoss S; Fagotti A; Narducci F; Matylevich O; Holly J; Martinelli F; Koual M; Kopetskyi V; El-Balat A; Corrado G; Căpîlna ME; Schröder W; Novàk Z; Shushkevich A; Fricová L; Cibula D
    Am J Obstet Gynecol; 2023 Apr; 228(4):443.e1-443.e10. PubMed ID: 36427596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of Follow-Up Methods in Patients After Fertility-Sparing Surgery for Cervical Cancers.
    Slama J; Fischerova D; Zikan M; Kocian R; Germanova A; Fruhauf F; Dusek L; Cibula D
    Int J Gynecol Cancer; 2017 Jan; 27(1):147-153. PubMed ID: 27668393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy prior to fertility-sparing surgery in cervical tumors larger than 2 cm: a systematic review on fertility and oncologic outcomes.
    Burbano J; Heredia F; Sanabria D; Ardila EG; Viveros-Carreño D; Rodriguez J
    Int J Gynecol Cancer; 2021 Mar; 31(3):387-398. PubMed ID: 33649006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility-sparing management for bulky cervical cancer using neoadjuvant transuterine arterial chemotherapy followed by vaginal trachelectomy.
    Tsubamoto H; Kanazawa R; Inoue K; Ito Y; Komori S; Maeda H; Hirota S
    Int J Gynecol Cancer; 2012 Jul; 22(6):1057-62. PubMed ID: 22683943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer.
    Robova H; Halaska MJ; Pluta M; Skapa P; Matecha J; Lisy J; Rob L
    Gynecol Oncol; 2014 Nov; 135(2):213-6. PubMed ID: 25159484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility-sparing surgery for early-stage cervical cancer: A case series study on the efficacy and feasibility of cervical conization followed by pelvic lymphadenectomy.
    Yamamoto M; Motohara T; Iwagoi Y; Tayama S; Tashiro H; Kondoh E; Katabuchi H
    J Obstet Gynaecol Res; 2022 Jun; 48(6):1444-1450. PubMed ID: 35315183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy after neoadjuvant chemotherapy for the IB1 cervical cancer: A series of 60 cases.
    Yan H; Liu Z; Fu X; Li Y; Che H; Mo R; Song L
    Int J Surg; 2016 May; 29():38-42. PubMed ID: 26975424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.